Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Thomas, Wündisch"'
Autor:
Fiona R. Rodepeter, Julia Teply-Szymanski, Marcel Romey, Albert Grass, Ramona Erber, Annette Lebeau, Elisabeth K. M. Mack, Thomas S. Tarawneh, Niklas Gremke, Jelena Boekhoff, Thomas Wündisch, Uwe Wagner, Paul Jank, Carsten Denkert
Publikováno v:
Die Pathologie. 44:39-49
Autor:
Sebastian Y. F. Michels, Andreas H. Scheel, Thomas Wündisch, Johannes M. Heuckmann, Roopika Menon, Michael Puesken, Carsten Kobe, Helen Pasternack, Carina Heydt, Matthias Scheffler, Rieke Fischer, Anne M. Schultheis, Sabine Merkelbach-Bruse, Lukas Heukamp, Reinhard Büttner, Jürgen Wolf
Publikováno v:
npj Precision Oncology, Vol 1, Iss 1, Pp 1-4 (2017)
Abstract Inflammatory myofibroblastic tumors are rare mesenchymal neoplasms frequently harboring oncogenic chromosomal rearrangements, most commonly, involving the ALK (anaplastic lymphoma kinase) gene. Treatment of this molecularly defined subgroup
Externí odkaz:
https://doaj.org/article/33a80232e38044a3a05d9a9bbd74b52a
Autor:
Christian Michel, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Andreas Neubauer, Michael Lauseker, Stefan W. Krause, Hans-Jochem Kolb, Dieter Kurt Hossfeld, Christoph Nerl, Gabriela M. Baerlocher, Dominik Heim, Tim H Brümmendorf, Alice Fabarius, Claudia Haferlach, Brigitte Schlegelberger, Leopold Balleisen, Maria-Elisabeth Goebeler, Mathias Hänel, Anthony Ho, Jolanta Dengler, Christiane Falge, Robert Möhle, Stephan Kremers, Michael Kneba, Frank Stegelmann, Claus-Henning Köhne, Hans-Walter Lindemann, Cornelius F. Waller, Karsten Spiekermann, Wolfgang E. Berdel, Lothar Müller, Matthias Edinger, Jiri Mayer, Dietrich W. Beelen, Martin Bentz, Hartmut Link, Bernd Hertenstein, Roland Fuchs, Martin Wernli, Frank Schlegel, Rudolf Schlag, Maike de Wit, Lorenz Trümper, Holger Hebart, Markus Hahn, Jörg Thomalla, Christof Scheid, Philippe Schafhausen, Walter Verbeek, Michael J. Eckart, Winfried Gassmann, Michael Schenk, Peter Brossart, Thomas Wündisch, Thomas Geer, Stephan Bildat, Erhardt Schäfer, Joerg Hasford, Rüdiger Hehlmann, Markus Pfirrmann
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
Standard first-line therapy of chronic myeloid leukemia is treatment with imatinib. In the randomized German Chronic Myeloid Leukemia-Study IV, more potent BCR-ABL inhibition with 800 mg (‘high-dose’) imatinib accelerated achievement of a deep mo
Externí odkaz:
https://doaj.org/article/8f2e3c990dda4c23bf1aba8a1a3b48ba
Supplementary Table 1 from Epigenetic Silencing of MicroRNA-203 Dysregulates ABL1 Expression and Drives Helicobacter-Associated Gastric Lymphomagenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7754ac88948db0c8a5680dd9ab8e39a8
https://doi.org/10.1158/0008-5472.22387662
https://doi.org/10.1158/0008-5472.22387662
Supplementary Table Legend from Epigenetic Silencing of MicroRNA-203 Dysregulates ABL1 Expression and Drives Helicobacter-Associated Gastric Lymphomagenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c821a63294b3606e3b56d942c45da7
https://doi.org/10.1158/0008-5472.22387659
https://doi.org/10.1158/0008-5472.22387659
Autor:
Thomas S. Tarawneh, Fiona R. Rodepeter, Julia Teply-Szymanski, Petra Ross, Vera Koch, Clemens Thölken, Jonas A. Schäfer, Niklas Gremke, Hildegard I. D. Mack, Judith Gold, Jorge Riera-Knorrenschild, Christian Wilhelm, Anja Rinke, Martin Middeke, Andreas Klemmer, Marcel Romey, Akira Hattesohl, Moritz Jesinghaus, Christian Görg, Jens Figiel, Ho-Ryun Chung, Thomas Wündisch, Andreas Neubauer, Carsten Denkert, Elisabeth K. M. Mack
Publikováno v:
Cancers; Volume 14; Issue 18; Pages: 4430
Background: Increasing knowledge of cancer biology and an expanding spectrum of molecularly targeted therapies provide the basis for precision oncology. Despite extensive gene diagnostics, previous reports indicate that less than 10% of patients bene
Autor:
Andreas Klameth, Philippe Kostrewa, Christian Wilhelm, Elisabeth Mack, Ralph Naumann, Ellen Wollmer, Mathias J. Rummel, S K Metzelder, Alexander Burchardt, Christoph Mann, Marius Dohse, Kristina Sohlbach, Heinz-Gert Hoeffkes, Corinna Trenker, Andreas Neubauer, Cornelia Brendel, Deborah Christen, Thomas Wündisch, Andreas Burchert
Publikováno v:
Leukemia & Lymphoma. 60:2056-2061
Patients who develop severe graft-versus-host disease (GvHD) after allogeneic stem cell transplantation (alloSCT) have a higher risk for invasive fungal infection (IFI). At our center, fluconazole prophylaxis is standard and upfront mold-effective pr
Autor:
Andreas, Burchert, Gesine, Bug, Lea V, Fritz, Jürgen, Finke, Matthias, Stelljes, Christoph, Röllig, Ellen, Wollmer, Ralph, Wäsch, Martin, Bornhäuser, Tobias, Berg, Fabian, Lang, Gerhard, Ehninger, Hubert, Serve, Robert, Zeiser, Eva-Maria, Wagner, Nicolaus, Kröger, Christine, Wolschke, Michael, Schleuning, Katharina S, Götze, Christoph, Schmid, Martina, Crysandt, Eva, Eßeling, Dominik, Wolf, Ying, Wang, Alexandra, Böhm, Christian, Thiede, Torsten, Haferlach, Christian, Michel, Wolfgang, Bethge, Thomas, Wündisch, Christian, Brandts, Susanne, Harnisch, Michael, Wittenberg, Heinz-Gert, Hoeffkes, Susanne, Rospleszcz, Alexander, Burchardt, Andreas, Neubauer, Markus, Brugger, Konstantin, Strauch, Carmen, Schade-Brittinger, Stephan K, Metzelder
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38(26)
Despite undergoing allogeneic hematopoietic stem cell transplantation (HCT), patients with acute myeloid leukemia (AML) with internal tandem duplication mutation in theIn a randomized, placebo-controlled, double-blind phase II trial (SORMAIN; German
Autor:
Martin Bornhäuser, Andreas Burchert, Susanne Harnisch, Michael Schleuning, Konstantin Strauch, Katharina Götze, Christian Michel, Christian Brandts, Ellen Wollmer, Susanne Rospleszcz, Thomas Wündisch, Alexandra Böhm, Fabian Lang, Alexander Burchardt, Jürgen Finke, Eva-Maria Wagner, Eva Eßeling, Nicolaus Kröger, Torsten Haferlach, Tobias Berg, Andreas Neubauer, Carmen Schade-Brittinger, Markus Brugger, Ying Wang, Dominik Wolf, S K Metzelder, Matthias Stelljes, Ralph Wäsch, Christine Wolschke, Gerhard Ehninger, Gesine Bug, Robert Zeiser, Hubert Serve, Martina Crysandt, Christian Thiede, Michael Wittenberg, Christoph Röllig, Christoph Schmid, Lea V. Fritz, Wolfgang Bethge, Heinz-Gert Hoeffkes
Publikováno v:
J. Clin. Oncol. 38, 2993-3002 (2020)
PURPOSE Despite undergoing allogeneic hematopoietic stem cell transplantation (HCT), patients with acute myeloid leukemia (AML) with internal tandem duplication mutation in the FMS-like tyrosine kinase 3 gene ( FLT3-ITD) have a poor prognosis, freque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36839bb69f3099cd0f1dfab0c2baaf2a
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=59685
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=59685
Autor:
Lukas C. Heukamp, Anne M. Schultheis, Helen Pasternack, Sabine Merkelbach-Bruse, Sebastian Michels, Thomas Wündisch, Matthias Scheffler, Rieke Fischer, Carina Heydt, Reinhard Büttner, Jürgen Wolf, Roopika Menon, Michael Puesken, Johannes M. Heuckmann, Carsten Kobe, Andreas H. Scheel
Publikováno v:
npj Precision Oncology, Vol 1, Iss 1, Pp 1-4 (2017)
NPJ Precision Oncology
NPJ Precision Oncology
Inflammatory myofibroblastic tumors are rare mesenchymal neoplasms frequently harboring oncogenic chromosomal rearrangements, most commonly, involving the ALK (anaplastic lymphoma kinase) gene. Treatment of this molecularly defined subgroup with the